Thursday, March 16, 2017

New Grant and Additional Investment by Freight and Logistics Pharma Interests in Benelux

Specialist Trade in Low Countries Continues To Expand as a Million Euros Invested
Shipping News Feature
NETHERLANDS – BELGIUM – LUXEMBOURG – Amsterdam Airport Schiphol is developing an early warning system for pharma shippers, a growing market for the Belelux countries, using a one million euro subsidy awarded by the Netherlands Organisation for Scientific Research (NWO), and TKI Dinalog, the Dutch Institute for Advanced Logistics. The money will fund data collection and monitoring of Pharma Gateway Amsterdam (PGA) freight shipments in order to identify exceptions such as temperature incursions. This data will then be used to design a model to alert shippers when there has been an issue with their consignment.

Schiphol has teamed up with Air France KLM Cargo, Cargonaut, and PGA members for the project, which starts this month with results expected later this year. Jonas van Stekelenburg, Cargo Director, Amsterdam Airport Schiphol said:

“We are listening to shippers’ needs and working to improve transparency and cooperation in the pharma supply chain. Pharma shippers are asking for more visibility so they can have confidence that their sensitive cargo is being handled safely through the supply chain and find solutions if there are issues such as temperature incursions. This research will enable us to develop a system capable of stepping up to those challenges.”

Marcel de Nooijer, EVP Air France KLM Cargo said his group was aware how important the specialist sector is with regard to the air freight industry worldwide. He commented:

”The pharmaceutical industry is a leading segment within the Air France KLM Cargo strategy. We are keen to improve the supply chain in collaboration with other parties in the chain, contributing to overall higher product integrity for pharmaceutical shipments."

Meanwhile logistics operator Kuehne + Nagel (K+N) has expanded its speciality trailer network in Belgium and Luxembourg by investing in 50 temperature-controlled pharma trailers to offer its customers state-of-the-art equipment that ensures the quality of their pharmaceutical products from pick-up to delivery.

The trailers are manufactured with aggregates that guarantee temperature control at all times through new built-in DAC (Discharge Air Control) and PTC (Precision Temperature Control) technology. This protects the cargo from any temperature deviation which is a key industry requirement as it reduces the risk of pharmaceutical products being damaged by frost. K+N says it is one of the first logistics providers equipped with such a large number of temperature-controlled trailers for serving the pharmaceutical industry Kevin Nash, Managing Director Kuehne + Nagel Belgium & Luxembourg said:

“We are committed to investing in best-in-class equipment to ensure our customers’ products arrive at their destination safe and completely intact through shipping fully compliant according to temperature guidelines. The expansion further solidifies KN PharmaChain as a leading pharma logistics service in Europe and as part of our global network.”